Clinical Trial Update: Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating treatment for febrile neutropenia patients suspected of Gram-positive infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Snippet

Sponsor: Pfizer | Conditions: Febrile Neutropenia | Phase 3 | Status: COMPLETED